bf/NASDAQ:IMCR_icon.jpeg

NASDAQ:IMCR

Immunocore Holdings plc

  • Stock

USD

Last Close

31.59

06/11 21:01

Market Cap

1.90B

Beta: 0.55

Volume Today

96.64K

Avg: 266.28K

PE Ratio

−53.27

PFCF: 257.21

OverviewFinancialsAPI

    Description

    Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1-0.52019-12-302021-01-152022-03-032023-08-102024-11-05

    Revenue (Estimate*)

    20M40M60M80M100M2019-12-302021-01-152022-03-032023-08-102024-11-05

    *Estimate based on analyst consensus